OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

ADVANCED MIC.DEV. DL-,01/  US0079031078  /

Lang & Schwarz
8/29/2024  2:41:32 PM Chg. +0.920 Volume Bid2:41:32 PM Ask2:41:32 PM Market Capitalization Dividend Y. P/E Ratio
131.140EUR +0.71% -
Turnover: -		 131.140Bid Size: - 131.340Ask Size: - 212.99 bill.EUR - -
TeleTrader 8/28 Dow down by 350 pts with tech sector in focus
GlobeNewswire 8/20 AMD to Present at the Deutsche Bank Technology Conference
GlobeNewswire 8/20 FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facil...
GlobeNewswire 8/20 Gamescom 2024 - HP Elevates the Gaming World through Customizable Solutions for a Personalized Playe...
TeleTrader 8/19 US closes higher on tech sell-off
TeleTrader 8/19 AMD to buy server maker ZT Systems for $4.9B
GlobeNewswire 8/19 AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solut...
GlobeNewswire 8/16 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 8/14 Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corp...
GlobeNewswire 8/12 Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corpo...
GlobeNewswire 8/12 Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 8/12 Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire 8/12 AMD Completes Acquisition of Silo AI to Accelerate Development and Deployment of AI Models on AMD Ha...
GlobeNewswire 8/12 Eclipse Life Sciences Initiates Phase 2 Study for Novel Ophthalmology Steroid Implant for Diabetic M...
GlobeNewswire 8/12 Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar po...
GlobeNewswire 8/9 Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire 8/8 4DMT Reports Second Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire 8/8 BOXX Workstations Feature New AMD Ryzen™ 9000 Series Processors
GlobeNewswire 8/8 Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire 8/8 Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conferen...
GlobeNewswire 8/8 EyePoint Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conferen...
GlobeNewswire 8/8 YieldMax™ Launches Option Income Strategy ETF on Alibaba (BABA)
GlobeNewswire 8/7 Outlook Therapeutics® to Report Financial Results for Third Quarter Fiscal Year 2024 on August 14, 2...
GlobeNewswire 8/7 Ocular Therapeutix™ Reports Second Quarter 2024 Results
GlobeNewswire 8/7 Ocular Therapeutix™ Announces FDA Feedback That SOL-R Trial is Appropriate as a Registrational Study...